Found 3 clinical trials
Effect of Sofosbuvir-daclatasuvir on Angiogenesis
The study aimed at study of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
- 0 views
- 13 Feb, 2022
- 1 location
Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan
This trial is linked to a largescale observational study determining the efficacy of sofosbuvir/daclatasvir in people in Pakistan (involving a separate protocol). The observational study will
- 0 views
- 14 Mar, 2022
- 1 location
Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir (STRIVE-4)
This study aims to evaluate the efficacy, safety and feasibility of four weeks of sofosbuvir plus glecaprevir-pibrentasvir, followed by immediate retreatment of virological relapse with glecepravir-pibrentasvir for 12 weeks, in treatment-naïve participants with chronic HCV infection and early liver disease (F0-F2).
- 0 views
- 27 Apr, 2022
- 3 locations